Trials / Completed
CompletedNCT02750228
PDA Post NICU Discharge
Patent Ductus Arteriosus Post NICU Discharge in Premature Infants: A Prospective Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 208 (actual)
- Sponsor
- Pediatrix · Academic / Other
- Sex
- All
- Age
- 22 Weeks – 32 Weeks
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to track post-discharge outcomes on prematurely born infants who are discharged from the NICU with a patent ductus arteriosus (PDA). Investigators plan to report on the spontaneous closure rate as well as the incidence of pulmonary and/or cardiac events in these infants. The goal is to identify risk factors associated with adverse outcomes in prematurely born infants who are sent home with a PDA.
Conditions
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2020-06-30
- Completion
- 2020-06-30
- First posted
- 2016-04-25
- Last updated
- 2020-06-30
Locations
16 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02750228. Inclusion in this directory is not an endorsement.